{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-25-004726","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2025-04-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.197065+00:00","generated_at":"2026-05-23T16:12:26.674971+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"confidence":"high","headline":"Outlook Therapeutics awards $237,500 retention bonus to CFO/Interim CEO Kenyon","bullets":["Cash retention bonus of $237,500 approved by Compensation Committee on April 9, 2025.","Bonus payable December 31, 2025, contingent on Kenyon's continuous employment through that date.","Kenyon declined option to receive stock options in lieu of cash; no election made.","Upon a qualifying termination before Dec 31, 2025, bonus accelerated subject to release of claims.","Retention bonus letter filed as Exhibit 10.1 with the 8-K."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-25-004726","json":"https://secwatch.observer/filing/0001558370-25-004726.json","markdown":"https://secwatch.observer/filing/0001558370-25-004726.md","text":"https://secwatch.observer/filing/0001558370-25-004726.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000155837025004726/0001558370-25-004726-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000155837025004726/otlk-20250409x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T16:12:26.674971+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}